The concerted actions of estrogen, ERa and mast cells in the development of prostatitis and prostate cancer.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Inflammation of the prostate (prostatitis) is exceedingly common. As inflammation has been linked to the development of cancer the prevalence of prostatitis is a significant health issue. Estrogens may cause inflammation, although how this occurs remains unknown. Mast cells may be involved and this study will examine how these cells and estrogen promote prostatitis and prostate cancer. This work will provide vital information to develop better treatments of prostatitis and prostate cancer.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: NHMRC Project Grants

Funding Amount: $365,126.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology and Carcinogenesis not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

endocrinology | hormones | inflammation | men's health | prostate cancer | prostate disease | urology